Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
Holding HCAT?
Track your performance easily
HCAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.42 - $11.41
Previous Close$7.36
Volume653.38K
Average Volume (3M)480.49K
Market Cap
$458.79M
Enterprise Value$435.87M
Total Cash (Recent Filing)$387.26M
Total Debt (Recent Filing)$364.33M
Price to Earnings (P/E)―
Beta1.86
Next Earnings
Mar 04, 2025EPS Estimate
$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.35
Shares Outstanding60,847,658
10 Day Avg. Volume555,026
30 Day Avg. Volume480,492
Standard Deviation0.15
R-Squared0.22
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.26
Price to Sales (P/S)1.52
Price to Cash Flow (P/CF)18.50
P/FCF Ratio21.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.44
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-12.85
Forecast
1Y Price Target
$10.95Price Target Upside42.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Health Catalyst News
PremiumCompany Announcements
Health Catalyst Reports Q3 Revenue Growth Amid Reduced LossesBulls Say, Bears Say
Bulls Say
Acquisition & ExpansionThe company announced a definitive agreement to acquire tech-enabled cybersecurity platform and services provider, Intraprise Health, for $43 million in cash and shares.
Financial Performance & GrowthHealth Catalyst posted a solid quarter in 3Q, beating consensus estimates and above the midpoint of quarterly guidance ranges.
Revenue & Margin OutlookManagement reiterated confidence in achieving the targeted double-digit revenue growth in 2025, supported by a robust pipeline skewed toward technology and higher margin professional services.
Bears Say
Cost ManagementCosts in ambulatory operations TEMS contracts was elevated in 3Q, contributing to lower expected professional services gross margin in 4Q.
Earnings PerformanceTEMS bookings came in lighter than expected which may dampen revenue growth in the near-term.
Revenue GrowthTech-enabled managed services (TEMS) bookings came in lighter than expected which may dampen revenue growth in the near-term.
---
Ownership Overview
11.40% Insiders
26.23% Mutual Funds
35.91% Other Institutional Investors
14.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $5.42 and its highest was $11.41 in the past 12 months.
What is Health Catalyst’s market cap?
Currently, no data Available
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Mar 04, 2025 which is in 102 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Nov 06, 2024. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.096 by -$0.026.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is $0.08.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 60,847,656 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.07 in its last earnings report, missing expectations of $0.096. Following the earnings report the stock price went up 7.394%.
Which hedge fund is a major shareholder of Health Catalyst?
Among the largest hedge funds holding Health Catalyst’s share is PRIMECAP Management Co. It holds Health Catalyst’s shares valued at 20M.
---
Health Catalyst Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.95 (42.95% Upside)
$10.95 (42.95% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 6.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 13.5%
Last 30 Days ▲ 21.4%
Last 30 Days ▲ 21.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.03%
12-Months-Change
Fundamentals
Return on Equity
-21.46%
Trailing 12-Months
Asset Growth
14.04%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
---
HCAT Earnings Call
Q3 2024
0:00 / 0:00
---
HCAT Stock 12 Month Forecast
Average Price Target
$10.95
▲(42.95% Upside)
Technical Analysis
Best Analysts Covering HCAT
1 Year
1 Year Success Rate
8/19 ratings generated profit
1 Year Average Return
-8.89%
reiterated a buy rating 16 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -8.89% per trade.
---